CytomX Therapeutics, Inc. Other Non-Current Liabilities
CytomX Therapeutics, Inc. (CTMX) had Other Non-Current Liabilities of $4.47 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Noncurrent $4.47M.
- 2026-03-31: Other Liabilities, Noncurrent $4.41M.
- 2025-12-31: Other Liabilities, Noncurrent $4.35M.
- 2025-09-30: Other Liabilities, Noncurrent $4.30M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $4.47M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $4.41M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $4.35M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $4.30M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $4.24M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $4.18M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $4.12M 10-K · filed 2026-03-16 |
| 2024-09-30 | $4.05M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.99M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.94M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $3.89M 10-K · filed 2025-03-06 |
| 2023-09-30 | $2.76M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $216.00K 10-Q · filed 2023-08-08 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-11 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 |
| 2019-12-31 | $850.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $963.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $963.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $963.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $3.05M 10-K · filed 2020-02-27 |
| 2018-09-30 | $2.43M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.28M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $2.06M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $1.90M 10-K · filed 2019-02-27 |
| 2017-09-30 | $1.80M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $1.39M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $978.00K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $566.00K 10-K · filed 2018-03-07 |
| 2016-09-30 | $154.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $153.00K 10-Q · filed 2016-08-03 |
| 2015-12-31 | $198.00K 10-K · filed 2017-03-02 |
| 2015-09-30 | $244.00K 10-Q · filed 2015-11-23 |
| 2014-12-31 | $249.00K 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |